Home › Epilepsy › Tennessee › Nashville
Epilepsy clinical trials in Nashville, TN
6 studies for Epilepsy are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
RecruitingPhase 3
- Vanderbilt University Medical Center, Nashville
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
RecruitingPhase 3
- Vanderbilt University Medical Center, Nashville
Physiological Brain Atlas Development
RecruitingObservational study
- Vanderbilt Univeristy, Nashville
Subcortical Arousal in Perceptual Awareness
Recruiting
- Vanderbilt University Medical Center, Nashville
Effect of Rose Odor Exposure on Ictal Apnea
RecruitingEarly phase 1
- Vanderbilt University Medical Center, Nashville
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA18 studies
- Houston, TX15 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Durham, NC9 studies
- Phoenix, AZ9 studies
- Rochester, MN9 studies
- Cleveland, OH9 studies
- Miami, FL8 studies
- Birmingham, AL7 studies
- Mountain View, CA6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer78 studies
- Metastatic Cancer69 studies
- Colorectal Cancer67 studies
- Cancer (all types)65 studies
- Ovarian Cancer50 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Prostate Cancer40 studies
- Pancreatic Cancer39 studies
- Lung Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.